Critical CareinflammationARDS
Interleukin-6 as a Central Mediator of Therapeutic Success in Acute Lung Injury and COVID-19
By MedXY|Aug 6, 2026
This article examines interleukin-6 (IL-6) as a key mediator of therapeutic efficacy in acute lung injury and COVID-19, highlighting its role in modulating inflammation and survival outcomes across multiple clinical interventions.